Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Jul 5, 2029 (in 1027 days)
Similar opportunities open now
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Oct 2027Up to $300K
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses in 37 daysUp to $600K
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses in 37 daysUp to $600K
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 2028Up to $500K
- NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses in 6 days
Classification and identifiers
- Solicitation number
- PAR-27-073
- Assistance listing (CFDA)
- 93.393
Amount
Amount not published by the funder
Who can apply
Small businesses, Local government agencies, and Nonprofits, including small and volunteer-run organizations can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
About this opportunity
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and sharing of data and biospecimen resources as appropriate.